Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Bionano Genomics Inc (BNGO)

8.55   -0.93 (-9.81%) 03-03 16:57
Open: 9.57 Pre. Close: 9.48
High: 9.59 Low: 8.45
Volume: 27,039,535 Market Cap: 2,324M
BioNano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. The company is headquartered in San Diego, California and currently employs 77 full-time employees. The firm develops and markets the Saphyr system. The Company’s products include Sequencing for Discovery Research and Cytogenetics. Sequencing alone, however, is significantly limited due to its inability to reveal structural variations. Cytogenetics provide a clinical diagnosis, cytogenetic tests detect known variations that are linked to specific diseases or therapeutic responses. Saphyr system is platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. Sequencing for Discovery Research is primarily used to find single nucleotide variations responsible for disease or therapeutic response.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 9.609 - 9.663 9.663 - 9.722
Low: 8.312 - 8.367 8.367 - 8.426
Close: 8.447 - 8.542 8.542 - 8.646

Technical analysis

as of: 2021-03-03 4:37:11 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 14.92     One year: 18.33
Support: Support1: 8.05    Support2: 6.70
Resistance: Resistance1: 12.77    Resistance2: 15.69
Pivot: 11.61
Moving Average: MA(5): 9.52     MA(20): 11.58
MA(100): 4.43     MA(250): 2.09
MACD: MACD(12,26): 0.15     Signal(9): 0.86
Stochastic oscillator: %K(14,3): 16.23     %D(3): 20.45
RSI: RSI(14): 41.89
52-week: High: 15.69  Low: 0.25  Change(%): 656.6
Average Vol(K): 3-Month: 8947078  10-Days: 2693384

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
BNGO has closed above bottom band by 11.5%. Bollinger Bands are 156.5% wider than normal. The large width of the bands suggest high volatility as compared to BNGO's normal range. The bands have been in this wide range for 11 bars. This is a sign that the current trend might continue.

Headline News

Wed, 03 Mar 2021
BioNano Genomics, Inc. (BNGO) Customer Praxis Genomics Receives DEX Z-Codes from Palmetto for their Whole Genome Analysis LDT on Saphyr - StreetInsider.com

Wed, 03 Mar 2021
Bionano Customer Praxis Genomics Receives DEX Z-Codes from Palmetto for their Whole Genome Analysis LDT on Saphyr - Yahoo Finance

Tue, 02 Mar 2021
Bionano Genomics Would Have Been a Great Find Months Ago - InvestorPlace

Mon, 01 Mar 2021
Bionano Genomics, Inc. (BNGO) Gains But Lags Market: What You Should Know - Yahoo Finance

Mon, 01 Mar 2021
Bionano to be Featured at AGBT 2021 with Presentations of Scientific Discoveries made with Saphyr in Psychiatric Disorders and Cancer - Yahoo Finance

Mon, 01 Mar 2021
Bionano Genomics' Second Chance - Seeking Alpha

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Diagnostics & Research
Shares Out. (M) 272
Shares Float (M) 152
% Held by Insiders 0.06
% Held by Institutions 5.64
Shares Short (K) 25,470
Shares Short P. Month (K) 8,480

Stock Financials

EPS -0.520
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 0.100
Profit Margin
Operating Margin -453.08
Return on Assets (ttm) -68.2
Return on Equity (ttm) -1021.6
Qtrly Rev. Growth -33.7
Gross Profit (p.s.) 0.012
Sales Per Share 0.027
EBITDA (p.s.) -0.117
Qtrly Earnings Growth
Operating Cash Flow (M) -36
Levered Free Cash Flow (M) -16

Stock Valuations

PE Ratio -16.44
PEG Ratio
Price to Book value 85.50
Price to Sales 318.38
Price to Cash Flow -65.30

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.